Fraunhofer in effort to develop robotic plant-based vax facility

The Fraunhofer Center for Molecular Biotechnology and its Center for Manufacturing Innovation have teamed with iBio Inc to develop an automated, scalable factory of sorts that uses plants for weeks-long vaccine production. Robotically tended machines plant seeds, nurture growing plants, introduce a viral vector to stimulate plant production of a target protein, and then harvest the biomass. Announcement

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.